Area:
Developmental Cell Ceath in the Nervous System
We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Kathleen M. McAvoy is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
2009 — 2011 |
Mcavoy, Kathleen M |
F31Activity Code Description: To provide predoctoral individuals with supervised research training in specified health and health-related areas leading toward the research degree (e.g., Ph.D.). |
The Role of the Von-Hippel Lindau Protein in Developmental Cell Death in Neurons @ University of Rochester
DESCRIPTION (provided by applicant): VHL is a tumor suppressor gene whose germline loss results in Von Hippel-Lindau disease, a hereditary cancer syndrome in which affected individuals have an increased rate of renal clear cell carcinoma, hemangioblastoma, and pheochromocytoma. Lee et al. (2005) showed that suppression of the VHL protein (pVHL) confers a survival advantage to nerve growth factor (NGF)-deprived sympathetic- neuron-like pheochromocytoma cells (PCI 2 cells). This and other evidence led to the hypothesis that loss of VHL in developing sympathoadrenal cells leads to an escape from normal programmed cell death, which may contribute to pheochromocytoma. A prerequisite for this hypothesis is that pVHL functions normally to regulate programmed cell death in cells of the sympathoadrenal lineage. The overall goal of this proposal is to examine the role of pVHL in developmental apoptosis in sympathetic neurons. Extensive cell death occurs as developing sympathetic neurons innverate their targets. Sympathetic neurons that successfully receive trophic support in the form of NGF survive, and those that do not undergo apoptosis. Here, we propose a novel function for pVHL based upon the following rationale: we have found that pVHL overexpression promotes death in sympathetic neurons, and preliminary data suggests that loss of pVHL delays death in sympathetic neurons after NGF deprivation. pVHL is a multifunctional protein best characterized for regulating the stability of hypoxia inducible factor (HIF) via ubiquitination, and we have recently found that HIF2alpha is a survival-promoting factor in these neurons. Further evidence suggests that pVHL may also regulate c-Jun and BIM-EL, both of which are known mediators of cell death after NGF deprivation. We hypothesize that pVHL regulates these specific pro-survival and pro-death factors (HIF, c-Jun, and/or BIM-EL), and that this regulation is required for apoptosis after NGF deprivation in sympathetic neurons. We propose two specific aims to determine the role of pVHL in cell death after NGF deprivation in sympathetic neurons:-1) we will use VHL loxP/loxP conditional knockout mice to test the hypothesis that pVHL loss in vitro will result in inhibition of apoptosis after NGF deprivation, and we will determine if this protection proceeds from changes in HIF, c-Jun, or BIM-EL and 2) we will use loxP/loxP Wntl-CRE mice to determine the effects of loss of pVHL in vivo in the developing sympathoadrenal lineage. This proposal will elucidate signaling events important for NGF deprivation and may describe functions of pVHL that, when lost could contribute to pheochromocytoma.
|
1 |